Colistimethate sodium powder and tobramycin powder for inhalation for the treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis: systematic review and economic model.
about
Current and future treatment options for cystic fibrosis lung disease: latest evidence and clinical implicationsColistimethate sodium dry powder for inhalation: a review of its use in the treatment of chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.An Early Health Economic Analysis of the Potential Cost Effectiveness of an Adherence Intervention to Improve Outcomes for Patients with Cystic Fibrosis.Cystic Fibrosis Airway Microbiome: Overturning the Old, Opening the Way for the New.
P2860
Colistimethate sodium powder and tobramycin powder for inhalation for the treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis: systematic review and economic model.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Colistimethate sodium powder a ...... tic review and economic model.
@ast
Colistimethate sodium powder a ...... tic review and economic model.
@en
type
label
Colistimethate sodium powder a ...... tic review and economic model.
@ast
Colistimethate sodium powder a ...... tic review and economic model.
@en
prefLabel
Colistimethate sodium powder a ...... tic review and economic model.
@ast
Colistimethate sodium powder a ...... tic review and economic model.
@en
P2093
P356
P1476
Colistimethate sodium powder a ...... tic review and economic model.
@en
P2093
P304
v-xvii, 1-181
P356
10.3310/HTA17560
P577
2013-12-01T00:00:00Z